The relevance of a geriatric assessment for elderly patients with a haematological malignancy - A systematic review

Leukemia Research

Volumn 38, Issue 3, 2014, Pages 275-283

  Hamaker, M E ^a   Prins, M C ^a   Stauder, R ^b  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Elderly; Geriatric assessment; Haematological malignancies; Prognostication

Indexed keywords

ELDERLY; GERIATRIC ASSESSMENT; HAEMATOLOGICAL MALIGNANCIES; PROGNOSTICATION;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COGNITION; DATABASES, BIBLIOGRAPHIC; FEMALE; GERIATRIC ASSESSMENT; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84894277140     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.12.018     Document Type: Review

References (34)

1. Muss H.B. Cancer in the elderly: a societal perspective from the United States. Clin Oncol (R Coll Radiol) 2009, 21(2):92-98.
2. Gundrum D.J., Go R.S. Cancer in the oldest old in the United Status: current statistics and projections. J Geriatr Oncol 2012, 3:299-306.
3. seer.cancer.gov; 2013.
4. Extermann M., Aapro M., Bernabei R., Cohen H.J., Droz J.P., Lichtman S., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55(3):241-252.
5. Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle-Ottowa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis 2012.
6. Corsetti M.T., Salvi F., Perticone S., Baraldi A., De P.L., Gatto S., et al. Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. Leuk Res 2011, 35(8):991-997.
7. Deschler B., Platzbecker U., Germing U., Lubbert M. Arrangement of parameters of a geriatric and quality of life assessment in elderly patients with myelodysplatic syndromes and acute myeloid leukemia during six months of different therapeutic modalities. Haematologica 2010, 95:109. abstract 0464.
8. Deschler B., Ihorst G., Platzbecker U., Germing U., Marz E., de Figuerido F.M., et al. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica 2013, 98(2):208-216.
9. Klepin H.D., Geiger A.M., Tooze J.A., Kritchevsky S.B., Williamson J.D., Pardee T.S., et al. Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood 2013, 121(21):4287-4294.
10. Klepin H.D., Geiger A.M., Tooze J.A., Kritchevsky S.B., Williamson J.D., Ellis L.R., et al. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc 2011, 59(10):1837-1846.
11. Muffly L.S., Boulukos M., Swanson K., Kocherginsky M., Cerro P.D., Schroeder L., et al. Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Transplant 2013, 19(3):429-434.
12. Ritchie E.K., Roboz G., Hinchcliff K., Curcio T., Scandura J., Feldman E. Phase I trial of laromustine in combination with infusional ara-C in elderly patients over age 60 with newly diagnosed AML or high-grade MDS. Journal of Clinical Oncology 2009, 27(15 (Suppl 1)):7054.
13. Rollot-Trad F., Lahjibi H., Lazarovici C., Bauer C., Saint-Jean O., Gisselbrecht M. Haematological malignancies in older adults: experience in a geriatric acute care department. Rev Med Interne 2008, 29(7):541-549.
14. Siegel A.B., Lachs M., Coleman M., Leonard J.P. Lymphoma in elderly patients: novel functional assessment techniques provide better discrimination among patients than traditional performance status measures. Clin Lymphoma Myeloma 2006, 7(1):65-69.
15. Soubeyran P., Khaled H., MacKenzie M., Debois M., Fortpied C., de Bock R., et al. Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly. J Geriatr Oncol 2011, 2:36-44.
16. Tucci A., Ferrari S., Bottelli C., Borlenghi E., Drera M., Rossi G. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 2009, 115(19):4547-4553.
17. Winkelmann N., Petersen I., Kiehntopf M., Fricke H.J., Hochhaus A., Wedding U. Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma. J Cancer Res Clin Oncol 2011, 137(4):733-738.
18. Soubeyran P., Fonck M., Blanc-Bisson C., Blanc J.F., Ceccaldi J., Mertens C., et al. Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 2012, 30(15):1829-1834.
19. Bellera C.A., Rainfray M., Mathoulin-Pelissier S., Mertens C., Delva F., Fonck M., et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012, 23(8):2166-2172.
20. Stauder R., Moser K., Holzner B., Sperner-Unterweger B., Kemmler G. Six independent domains are defined by geriatric assessment in elderly cancer patients. Crit Rev Oncol Hematol 2010, 74(2):97-105.
21. Wedding U., Kodding D., Pientka L., Steinmetz H.T., Schmitz S. Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy. Crit Rev Oncol Hematol 2007, 64(1):1-9.
22. Wedding U., Rohrig B., Klippstein A., Pientka L., Hoffken K. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 2007, 133(12):945-950.
23. Wildes T.M., Ruwe A.P., Fournier C., Gao F., Carson K.R., Piccirillo J.F., et al. Geriatric assessment is associated with completion of chemotherapy, toxicity and survival in older adults with cancer. J Geriatr Oncol 2013, 4(3):227-234.
24. Stauder R. The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients. Ann Hematol 2012, 91(9):1333-1343.
25. Balducci L., Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000, 5(3):224-237.
26. Rao A.V., Hsieh F., Feussner J.R., Cohen H.J. Geriatric evaluation and management units in the care of the frail elderly cancer patient. J Gerontol A Biol Sci Med Sci 2005, 60(6):798-803.
27. Chaibi P., Magne N., Breton S., Chebib A., Watson S., Duron J.J., et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2011, 79(3):302-307.
28. Aparicio T., Girard L., Bouarioua N., Patry C., Legrain S., Soule J.C. A mini geriatric assessment helps treatment decision in elderly patients with digestive cancer. A pilot study. Crit Rev Oncol/Hematol 2011, 77(1):63-69.
29. Horgan A.M., Leighl N.B., Coate L., Liu G., Palepu P., Knox J.J., et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol 2012, 35(4):322-328.
30. Extermann M., Meyer J., McGinnis M., Crocker T.T., Corcoran M.B., Yoder J., et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 2004, 49(1):69-75.
31. Caillet P., Canoui-Poitrine F., Vouriot J., Berle M., Reinald N., Krypciak S., et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011, 29(27):3636-3642.
32. Kenis C., Bron D., Libert Y., Decoster L., Van P.K., Scalliet P., et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013, 24(5):1306-1312.
33. 2013. http://www.clinicaltrialsregister.eu/.
34. 2013. http://www.clinicaltrials.gov/.